Ding Zhou
Director Ejecutivo en Shanghai Zanrong Pharmaceutical Technology Co., Ltd. .
Cargos activos de Ding Zhou
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Shanghai Zanrong Pharmaceutical Technology Co., Ltd.
Shanghai Zanrong Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Zion Pharma Ltd., Shanghai Zanrong Pharmaceutical Technology Co., Ltd. is a company that develops small molecule anti-tumour drugs. The company is based in Shanghai, China. The Chinese company was founded in 2018. The CEO is Ding Zhou. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - | |
Zion Pharma Ltd.
Zion Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Zion Pharma Ltd. is a private, Chinese clinical stage biotech company founded in 2018. The company's research operations are located in mainland China and they have additional research operations elsewhere. The company is based in China and has subsidiaries in the country. The company is focused on developing novel, small molecule, anti-tumoral agents using an innovative drug discovery approach. Zion Pharma is capitalizing on its dmpk expertise to develop a pipeline of proprietary first-in-class/best-in-class compounds focused on therapeutic targets which drive tumor inhibition, including ataxia telangiectasia mutated (atm), kirsten rat sarcoma (kras g12d) and smarca2 (brm). | Director/Miembro de la Junta | 01/01/2018 | - |
Director Técnico/Científico/I+D | 01/01/2018 | - | |
Fundador | 01/01/2018 | - |
Historial de carrera de Ding Zhou
Estadísticas
Internacional
China | 3 |
Operativa
Director/Board Member | 2 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorial
Commercial Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Zion Pharma Ltd.
Zion Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Zion Pharma Ltd. is a private, Chinese clinical stage biotech company founded in 2018. The company's research operations are located in mainland China and they have additional research operations elsewhere. The company is based in China and has subsidiaries in the country. The company is focused on developing novel, small molecule, anti-tumoral agents using an innovative drug discovery approach. Zion Pharma is capitalizing on its dmpk expertise to develop a pipeline of proprietary first-in-class/best-in-class compounds focused on therapeutic targets which drive tumor inhibition, including ataxia telangiectasia mutated (atm), kirsten rat sarcoma (kras g12d) and smarca2 (brm). | Commercial Services |
Shanghai Zanrong Pharmaceutical Technology Co., Ltd.
Shanghai Zanrong Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Zion Pharma Ltd., Shanghai Zanrong Pharmaceutical Technology Co., Ltd. is a company that develops small molecule anti-tumour drugs. The company is based in Shanghai, China. The Chinese company was founded in 2018. The CEO is Ding Zhou. | Health Technology |
- Bolsa de valores
- Insiders
- Ding Zhou
- Experiencia